Pharmacology

Action Mechanism of Action Reference
INHIBITOR Telomerase reverse transcriptase inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 2 D001943 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Lung Neoplasms 1 D008175 ClinicalTrials

Related Entries

Parent

Cross References

Resources Reference
ChEMBL CHEMBL2108702
FDA SRS 2AW48LAZ4I
PubChem 72941968